A detailed history of Investment Partners, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Investment Partners, Ltd. holds 17,027 shares of ABBV stock, worth $2.9 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
17,027
Previous 17,010 0.1%
Holding current value
$2.9 Million
Previous $2.92 Million 15.26%
% of portfolio
1.41%
Previous 1.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $2,785 - $3,388
17 Added 0.1%
17,027 $3.36 Million
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $23,063 - $26,933
149 Added 0.88%
17,010 $2.92 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $2.13 Million - $2.43 Million
13,319 Added 376.03%
16,861 $3.07 Million
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $3,027 - $3,409
22 Added 0.63%
3,542 $548,000
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $189,297 - $219,139
1,417 Added 67.38%
3,520 $524,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $424,429 - $528,174
-3,203 Reduced 60.37%
2,103 $283,000
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $5,205 - $5,995
36 Added 0.68%
5,306 $845,000
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $542,313 - $650,376
-3,921 Reduced 42.66%
5,270 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $535,632 - $614,334
3,991 Added 76.75%
9,191 $1.23 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $4,679 - $5,948
34 Added 0.66%
5,200 $796,000
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $2,507 - $3,111
19 Added 0.37%
5,166 $838,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $116,131 - $146,940
1,081 Added 26.59%
5,147 $697,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $2,234 - $2,536
21 Added 0.52%
4,066 $439,000
Q2 2021

Jul 15, 2021

SELL
$105.21 - $117.21 $66,282 - $73,842
-630 Reduced 13.48%
4,045 $456,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $478,252 - $526,498
4,675 New
4,675 $506,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $188,400 - $221,120
-2,193 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $160,900 - $215,308
2,193 New
2,193 $215,000
Q1 2020

Apr 29, 2020

SELL
$64.5 - $97.79 $147,705 - $223,939
-2,290 Closed
0 $0
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $165,177 - $206,672
2,290 New
2,290 $203,000
Q3 2019

Oct 17, 2019

SELL
$62.98 - $75.72 $522,419 - $628,097
-8,295 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $56,042 - $71,634
853 Added 11.46%
8,295 $603,000
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $5,862 - $6,900
-76 Reduced 1.01%
7,442 $600,000
Q4 2018

Jan 15, 2019

BUY
$77.85 - $96.01 $585,276 - $721,803
7,518 New
7,518 $693,000
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $689,852 - $766,899
-7,759 Closed
0 $0
Q2 2018

Jul 25, 2018

SELL
$89.78 - $106.23 $19,212 - $22,733
-214 Reduced 2.68%
7,759 $719,000
Q1 2018

May 03, 2018

BUY
$92.01 - $123.21 $195,337 - $261,574
2,123 Added 36.29%
7,973 $755,000
Q4 2017

Jan 31, 2018

BUY
$89.56 - $98.21 $6,000 - $6,580
67 Added 1.16%
5,850 $566,000
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $403,942 - $515,959
5,783
5,783 $514,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investment Partners, Ltd. Portfolio

Follow Investment Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Investment Partners, Ltd. with notifications on news.